Anthropometry and prostate cancer risk: A prospective study of 22,248 Norwegian men

Cancer Causes and Control

Volumn 10, Issue 4, 1999, Pages 269-275

  Lund Nilsen, Tom I ^a,b   Vatten, Lars J ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b Kreftforeningen   (Norway)

Author keywords

Anthropometry; Epidemiology; Prospective studies; Prostate cancer; Risk

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BODY HEIGHT; BODY MASS; BODY SIZE; BODY WEIGHT; CANCER RISK; HUMAN; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; NORWAY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; REGRESSION ANALYSIS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BODY HEIGHT; BODY WEIGHT; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0032784599     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008967330619     Document Type: Article

References (47)

1. Landis SH, Murray T, Bolden S, Wingo PA (1998) Cancer statistics, 1998. CA Cancer J Clin 48: 6-29.
2. Cancer Registry of Norway (1998) Cancer in Norway 1995. Oslo: Cancer Registry of Norway, p. 98.
3. Ross RK, McCurtis JW, Henderson BE, Menck HR, Mack TM, Martin SP (1979) Descriptive epidemiology of testicular and prostatic cancer in Los Angeles. Br J Cancer 39: 284-292.
4. Haas GP, Sakr WA (1997) Epidemiology of prostate cancer. CA Cancer J Clin 47: 273-287.
5. Muir C, Nectoux J, Staszewski J (1991) The epidemiology of prostatic cancer: geographical distribution and time-trends. Acta Oncologica 30: 133-140.
6. Parker SL, Davis KJ, Wingo PA, Ries LA, Heath CW Jr (1998) Cancer statistics by race and ethnicity. CA Cancer J Clin 48: 31-48.
7. Haenszel W, Kurihara M (1968) Studies of Japanese migrants. I. Mortality from cancer and other diseases among Japanese in the United States. J Natl Cancer Inst 40: 43-68.
8. Kolonel LN (1996) Nutrition and prostate cancer. Cancer Causes Control 7: 83-94.
9. Tibblin G, Eriksson M, Cnattingius S, Ekbom A (1995) High birthweight as a predictor of prostate cancer risk. Epidemiology 6: 423-424.
10. Ekbom A, Hsieh CC, Lipworth L et al. (1996) Perinatal charac-teristics in relation to incidence of and mortality from prostate cancer. BMJ 313: 337-341.
11. Platz EA, Giovannucci E, Rimm EB, et al. (1998) Retrospective analysis of birth weight and prostate cancer in the Health Professionals Follow-up Study. Am J Epidemiol 147: 1140-1144.
12. Wilding G (1995) Endocrine control of prostate cancer. Cancer Surv 23: 43-62.
13. Ross R, Bernstein L, Judd H, Hanisch R, Pike M, Henderson B (1986) Serum testosterone levels in healthy young black and white men. J Natl Cancer Inst 76: 45-48.
14. Iwamura M, Sluss PM, Casamento JB, Cockett AT (1993) Insulin-like growth factor I: action and receptor characterization in human prostate cancer cell lines. Prostate 22: 243-252.
15. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ (1996) Prospective study of sex hormone levels and risk of prostate cancer. J Natl Cancer Inst 88: 1118-1126.
16. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami HO (1997) Insulin-like growth factor I in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 76: 1115-1118.
17. Juul A, Bang P, Hertel NT, et al. (1994) Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab 78: 744-752.
18. Chan JM, Stampfer MJ, Giovannucci E, et al. (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279: 563-566.
19. Albanes D, Jones DY, Schatzkin A, Micozzi MS, Taylor PR (1988) Adult stature and risk of cancer. Cancer Res 48: 1658-1662.
20. Severson RK, Grove JS, Nomura AM, Stemmermann GN (1988) Body mass and prostatic cancer: a prospective study. BMJ 297: 713-715.
21. La Vecchia C, Negri E, Parazzini F, et al. (1990) Height and cancer risk in a network of case-control studies from northern Italy. Int J Cancer 45: 275-279.
22. Andersson SO, Baron J, Bergstrom R, Lindgren C, Wolk A, Adami HO (1996) Lifestyle factors and prostate cancer risk: a case control study in Sweden. Cancer Epidemiol Biomarkers Prev 5: 509-513
23. Cerhan JR, Torner JC, Lynch CF, et al. (1997) Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65 + Rural Health Study (United States). Cancer Causes Control 8: 229-238.
24. Demark-Wahnefried W, Conaway MR, Robertson CN, Mathias BJ, Anderson EE, Paulson DF (1997) Anthropometric risk factors for prostate cancer. Nutr Cancer 28: 302-307.
25. Barker DJ, Osmond C, Golding J (1990) Height and mortality in the counties of England and Wales. Ann Hum Biol 17: 1-6.
26. Andersson SO, Wolk A, Bergstrom R, et al. (1997) Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst 89: 385-389.
27. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6: 557-563.
28. Hebert PR, Ajani U, Cook NR, Lee IM, Chan KS, Hennekens CH (1997) Adult height and incidence of cancer in male physicians (United States). Cancer Causes Control 8: 591-597.
29. Giovannucci E, Rimm EB, Colditz GA, et al. (1993) A prospective study of dietary fat and risk of prostate cancer. J Natl Cancer Inst 85: 1571 -1579.
30. Hartman TJ, Albanes D, Rautalahti M, et al. (1998) Physical activity and prostate cancer in the Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study, Cancer Causes Control 9: 11-18.
31. Thune I, Lund E (1994) Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men. Cancer Causes Control 5: 549-556.
32. Hayes RB, de Jong FH, Raatgever J, et al. (1992) Physical characteristics and factors related to sexual development and behaviour and the risk for prostatic cancer. Eur J Cancer Prev 1: 239-245.
33. Chyou PH, Nomura AM, Stemmermann GN (1994) A prospective study of weight, body mass index and other anthropometric measurements in relation to site-specific cancers, Int J Cancer 57: 313-317.
34. Nomura A, Heilbrun LK, Stemmermann GN (1985) Body mass index as a predictor of cancer in men. J Natl Cancer Inst 74: 319-323.
35. Moller H, Mellemgaard A, Lindvig K, Olsen JH (1994) Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A: 344-350.
36. Whittemore AS, Kolonel LN, Wu AH, et al. (1995) Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada. J Natl Cancer Inst 87: 652-661.
37. Gronberg H, Damber L, Damber JE (1996) Total food consumption and body mass index in relation to prostate cancer risk: a case-control study in Sweden with prospectively collected exposure data. J Urol 155: 969-974.
38. Garn SM, Leonard WR, Hawthorne VM (1986) Three limitations of the body mass index. Am J Clin Nutr 44: 996-997.
39. Holmen J, Midthjell K (1990) The Nord-TrØndelag health survey 1984-86: purpose, background and methods: participation, non- participation and frequency. Oslo: SIFF, Helsetjenesteforskning, p. 257.
40. Harvei S, Tretli S, Langmark F (1996) Quality of prostate cancer data in the cancer registry of Norway. Eur J Cancer 32A: 104-110.
41. Watson PE, Watson ID, Batt RD (1980) Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 33: 27-39.
42. Kleinbaum DG (1995) Survival Analysis: a self-learning text. New York: Springer-Verlag, p. 324.
43. Signorello LB, Tzonou A, Mantzoros CS, et al. (1997) Serum steroids in relation to prostate cancer risk in a case control study (Greece). Cancer Causes Control 8: 632-636.
44. Vatten LJ, Ursin G, Ross RK, et al. (1997) Androgens in serum and the risk of prostate cancer: a nested case control study from the Janus serum bank in Norway. Cancer Epidemiol Biomarkers Prev 6: 967-969.
45. LeRoith D, Baserga R, Helman L, Roberts CT Jr (1995) Insulin-like growth factors and cancer. Ann Intern Med 122: 54-59.
46. Horton R, Pasupuletti V, Antonipillai I (1993). Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I. Endocrinology 133: 447-451.
47. Wolk A, Mantzoros CS, Andersson SO, et al. (1998) Insulin-like growth factor I and prostate cancer risk: a population-based, case control study. J Natl Cancer Inst 90: 911-915.